Holen Sie sich die Stockscreener-App
2.46
2.72%
-0.08
Schlusskurs vom Vortag:
$2.54
Offen:
$2.5
24-Stunden-Volumen:
137.41K
Relative Volume:
0.36
Marktkapitalisierung:
$129.80M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.44%
1M Leistung:
-4.97%
6M Leistung:
-36.97%
1J Leistung:
-54.91%
1-Tages-Spanne:
$2.44
$2.54
1-Wochen-Bereich:
$2.38
$2.59
52-Wochen-Spanne:
$1.80
$7.20
Tuhura Biosciences Inc Stock (HURA) Company Profile
Firmenname
Tuhura Biosciences Inc
Sektor
Branche
Telefon
813-875-6600
Adresse
10500 UNIVERSITY CENTER DR., TAMPA
Vergleichen Sie HURA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HURA
Tuhura Biosciences Inc
|
2.46 | 129.80M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.22 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.22 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.73 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.59 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.82 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tuhura Biosciences Inc Stock (HURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-19 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-11-05 | Eingeleitet | Maxim Group | Buy |
Tuhura Biosciences Inc Aktie (HURA) Neueste Nachrichten
TuHURA Biosciences Announces $50M Stock Offering Agreement - TipRanks
How interest rate cuts could boost TuHURA Biosciences Inc. stockJuly 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - newser.com
How to build a custom watchlist for TuHURA Biosciences Inc.2025 Price Targets & Weekly High Return Opportunities - newser.com
Why analysts raise outlook for TuHURA Biosciences Inc. (PL3) stockQuarterly Trade Review & Accurate Technical Buy Alerts - newser.com
Applying Wyckoff theory to TuHURA Biosciences Inc. stockCEO Change & Stock Market Timing Techniques - newser.com
Multi factor analysis applied to TuHURA Biosciences Inc.2025 Momentum Check & Weekly Chart Analysis and Guides - newser.com
TuHURA’s research on delta opioid receptor in cancer therapy to be presented at ASH meeting - Investing.com Nigeria
TuHURA Biosciences Plans Phase 2 Trial for TBS-2025 - TipRanks
TuHURA Biosciences cancer research accepted for ASH presentation By Investing.com - Investing.com South Africa
TuHURA Biosciences cancer research accepted for ASH presentation - Investing.com
What the charts say about TuHURA Biosciences Inc. todayTrade Volume Report & Real-Time Chart Breakout Alerts - newser.com
TuHURA (NASDAQ: HURA) to present DOR-MDSC oral data at 67th ASH; TAM results included - Stock Titan
Will TuHURA Biosciences Inc. (PL3) stock draw ESG focused fundsJuly 2025 Intraday Action & Low Drawdown Investment Strategies - newser.com
How to integrate TuHURA Biosciences Inc. into portfolio analysis tools2025 Volatility Report & Verified Entry Point Detection - newser.com
Can machine learning forecast TuHURA Biosciences Inc. recovery2025 Price Action Summary & Low Risk Entry Point Tips - newser.com
Is it too late to sell TuHURA Biosciences Inc.Trade Risk Summary & Safe Entry Momentum Tips - newser.com
What earnings revisions data tells us about TuHURA Biosciences Inc.Weekly Volume Report & Safe Capital Growth Trade Ideas - newser.com
What moving averages say about TuHURA Biosciences Inc.Bull Run & Fast Exit/Entry Strategy Plans - newser.com
Will TuHURA Biosciences Inc. rebound enough to break even2025 Biggest Moves & AI Powered Buy/Sell Recommendations - newser.com
Is TuHURA Biosciences Inc. stock in correction or buying zoneJuly 2025 Sentiment & Expert Verified Movement Alerts - newser.com
Will TuHURA Biosciences Inc. (PL3) stock hit analyst forecastsTrade Exit Report & Low Drawdown Trading Strategies - newser.com
How TuHURA Biosciences Inc. (PL3) stock valuation compares with sectorWeekly Market Outlook & Low Volatility Stock Recommendations - newser.com
TuHURA Biosciences Inc. stock volume spike explainedWeekly Gains Summary & Technical Entry and Exit Tips - newser.com
How TuHURA Biosciences Inc. stock benefits from strong dollarRecession Risk & AI Based Buy and Sell Signals - newser.com
Is TuHURA Biosciences Inc. stock gaining market shareJuly 2025 EndofMonth & Precise Swing Trade Entry Alerts - newser.com
Can TuHURA Biosciences Inc. (PL3) stock retain market dominance2025 Volume Leaders & Verified Entry Point Signals - newser.com
Will TuHURA Biosciences Inc. bounce back from current supportOil Prices & Weekly Top Gainers Trade List - newser.com
Multi asset correlation models including TuHURA Biosciences Inc.Rate Cut & Low Risk Growth Stock Ideas - newser.com
Is TuHURA Biosciences Inc. stock a safe investment in uncertain marketsMarket Performance Recap & Daily Technical Stock Forecast Reports - newser.com
TuHURA Biosciences Secures $3M Bridge Loan Agreement - MSN
Using Ichimoku Cloud for TuHURA Biosciences Inc. technicals2025 Year in Review & Short-Term Trading Opportunity Alerts - newser.com
Can technical indicators confirm TuHURA Biosciences Inc.’s reversal2025 Historical Comparison & Weekly Top Gainers Trade List - newser.com
Will TuHURA Biosciences Inc. (PL3) stock deliver compounding returnsJuly 2025 Setups & Fast Entry Momentum Trade Alerts - newser.com
Finanzdaten der Tuhura Biosciences Inc-Aktie (HURA)
Es liegen keine Finanzdaten für Tuhura Biosciences Inc (HURA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):